geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive... Immune Cell Agonist® (Bicycle TICA®) targeting Nectin-4 and agonizing CD137, in company-sponsored clinical trials...
Bicycle Therapeutics